Neda Rahimian

1.2k total citations
45 papers, 825 citations indexed

About

Neda Rahimian is a scholar working on Molecular Biology, Cancer Research and Infectious Diseases. According to data from OpenAlex, Neda Rahimian has authored 45 papers receiving a total of 825 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 17 papers in Cancer Research and 7 papers in Infectious Diseases. Recurrent topics in Neda Rahimian's work include MicroRNA in disease regulation (14 papers), Circular RNAs in diseases (12 papers) and Cancer-related molecular mechanisms research (9 papers). Neda Rahimian is often cited by papers focused on MicroRNA in disease regulation (14 papers), Circular RNAs in diseases (12 papers) and Cancer-related molecular mechanisms research (9 papers). Neda Rahimian collaborates with scholars based in Iran, South Africa and United States. Neda Rahimian's co-authors include Hamed Mirzaei, Michael R. Hamblin, Javid Sadri Nahand, Hamid Reza Mirzaei, Vida Tajiknia, Zahra Razavi, Mohammad Saeid Ebrahimi, Mohammad Taghizadieh, Maryam Mahjoubin‐Tehran and Saereh Hosseindoost and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and European Journal of Pharmacology.

In The Last Decade

Neda Rahimian

40 papers receiving 821 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Neda Rahimian Iran 16 604 523 68 58 44 45 825
Jayakumar Jerobin Qatar 9 530 0.9× 218 0.4× 67 1.0× 109 1.9× 42 1.0× 25 820
Jianjun Jin China 12 482 0.8× 301 0.6× 34 0.5× 74 1.3× 49 1.1× 28 690
Vagner Oliveira Carvalho Rigaud Brazil 16 293 0.5× 177 0.3× 113 1.7× 42 0.7× 39 0.9× 27 621
Qingxin Wang China 13 322 0.5× 148 0.3× 64 0.9× 26 0.4× 66 1.5× 34 602
Yuan Dang China 14 368 0.6× 290 0.6× 46 0.7× 111 1.9× 155 3.5× 35 660
Yohei Sato Japan 14 442 0.7× 221 0.4× 73 1.1× 240 4.1× 47 1.1× 46 852
Katharine J. Goodall Australia 9 431 0.7× 153 0.3× 50 0.7× 199 3.4× 31 0.7× 12 646
Gülçin Özer United States 5 1.1k 1.8× 949 1.8× 56 0.8× 297 5.1× 85 1.9× 7 1.4k

Countries citing papers authored by Neda Rahimian

Since Specialization
Citations

This map shows the geographic impact of Neda Rahimian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neda Rahimian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neda Rahimian more than expected).

Fields of papers citing papers by Neda Rahimian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neda Rahimian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neda Rahimian. The network helps show where Neda Rahimian may publish in the future.

Co-authorship network of co-authors of Neda Rahimian

This figure shows the co-authorship network connecting the top 25 collaborators of Neda Rahimian. A scholar is included among the top collaborators of Neda Rahimian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neda Rahimian. Neda Rahimian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mirzaei, Seyed Abbas, et al.. (2025). Metal nanoparticles and sensitivity/resistance to therapy in cancer: two sides of the coin?. Journal of Nanoparticle Research. 27(2).
2.
Jafari, Ameneh, et al.. (2025). Circular RNAs and Cancers. Advances in experimental medicine and biology. 1485. 273–327. 2 indexed citations
3.
Chen, Xiuli, et al.. (2024). Circular RNAs as a novel class of potential therapeutic and diagnostic biomarkers in reproductive biology/diseases. European journal of medical research. 29(1). 643–643. 4 indexed citations
4.
Mahabady, Mahmood Khaksary, et al.. (2024). NF-κB pathway and angiogenesis: insights into colorectal cancer development and therapeutic targets. European journal of medical research. 29(1). 610–610. 28 indexed citations
5.
Jafari, Seyed Hamed, et al.. (2024). Imaging Techniques and Biochemical Biomarkers: New Insights into Diagnosis of Pancreatic Cancer. Cell Biochemistry and Biophysics. 82(4). 3123–3144. 1 indexed citations
6.
Anoushirvani, Ali Arash, et al.. (2024). Nano fuzzy alarming system for blood transfusion requirement detection in cancer using deep learning. Scientific Reports. 14(1). 15958–15958. 1 indexed citations
7.
Khamseh, Mohammad E., Mojtaba Malek, Nahid Hashemi‐Madani, et al.. (2023). Guideline for the diagnosis and treatment of diabetes mellitus in patients with transfusion-dependent thalassemia. 15(4). 293–303. 1 indexed citations
8.
Naghizadeh, Mohammad Mehdi, et al.. (2023). Effect of tofacitinib on clinical and laboratory findings in severe and resistant patients with COVID-19. International Immunopharmacology. 122. 110565–110565. 4 indexed citations
9.
Rahimian, Neda, et al.. (2023). Non-coding RNAs and exosomal non-coding RNAs in pituitary adenoma. Pathology - Research and Practice. 248. 154649–154649. 2 indexed citations
10.
Tameshkel, Fahimeh Safarnezhad, Alireza Tabibzadeh, Mitra Ranjbar, et al.. (2023). A Retrospective Study on the Gam-COVID-Vac (Sputnik V) COVID-19 Vaccine Short-Term Efficacy and Side Effects in Iranian Healthcare Providers. Archives of Clinical Infectious Diseases. 18(3).
11.
Mottaghi, Azadeh, et al.. (2023). Serum cystatin C and inflammatory factors related to COVID-19 consequences. BMC Infectious Diseases. 23(1). 339–339. 8 indexed citations
12.
Rajabi, A. A., Majid Nejati, Mina Homayoonfal, et al.. (2023). Doxorubicin-loaded zymosan nanoparticles: Synergistic cytotoxicity and modulation of apoptosis and Wnt/β-catenin signaling pathway in C26 colorectal cancer cells. International Journal of Biological Macromolecules. 260(Pt 2). 128949–128949. 9 indexed citations
13.
Mirzaei, Hamed, Neda Rahimian, Hamid Reza Mirzaei, Javid Sadri Nahand, & Michael R. Hamblin. (2022). Exosomes and MicroRNAs in Biomedical Science. 13 indexed citations
14.
Letafati, Arash, Sajad Najafi, Mohammad Reza Karimzadeh, et al.. (2022). MicroRNA let-7 and viral infections: focus on mechanisms of action. Cellular & Molecular Biology Letters. 27(1). 14–14. 89 indexed citations
15.
Rahimian, Neda, Javid Sadri Nahand, Michael R. Hamblin, & Hamed Mirzaei. (2022). Exosomal MicroRNA Profiling. Methods in molecular biology. 2595. 13–47. 37 indexed citations
16.
Dashti, Fatemeh, Seyed Mohammad Ali Mirazimi, Massoud Vosough, et al.. (2021). The role of non-coding RNAs in chemotherapy for gastrointestinal cancers. Molecular Therapy — Nucleic Acids. 26. 892–926. 26 indexed citations
17.
Nahand, Javid Sadri, Mohammad Taghizadieh, Mohammad Saeid Ebrahimi, et al.. (2021). Oncogenic viruses and chemoresistance: What do we know?. Pharmacological Research. 170. 105730–105730. 33 indexed citations
18.
Rahimian, Neda, et al.. (2021). Non-coding RNAs related to angiogenesis in gynecological cancer. Gynecologic Oncology. 161(3). 896–912. 44 indexed citations
19.
Pourhanifeh, Mohammad Hossein, et al.. (2021). Roles of Non-coding RNAs and Angiogenesis in Glioblastoma. Frontiers in Cell and Developmental Biology. 9. 716462–716462. 55 indexed citations
20.
Rahimian, Neda, et al.. (2021). The Prevalence of Asthma among Iranian Children and Adolescent: A Systematic Review and Meta‐Analysis. Oxidative Medicine and Cellular Longevity. 2021(1). 6671870–6671870. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jayakumar Jerobin Breakdown of academic impact, for papers by Jianjun Jin Breakdown of academic impact, for papers by Vagner Oliveira Carvalho Rigaud Breakdown of academic impact, for papers by Qingxin Wang Breakdown of academic impact, for papers by Yuan Dang Breakdown of academic impact, for papers by Yohei Sato Breakdown of academic impact, for papers by Katharine J. Goodall Breakdown of academic impact, for papers by Gülçin Özer
Rankless by CCL
2026